Clinical features and biomarker differences of severe intrinsic and extrinsic atopic dermatitis

References

• Kader HA, Azeem M, Jwayed SA, et al. Current insights into immunology and novel therapeutics of atopic dermatitis. Cells. 2021;10(6):1392. doi:10.3390/cells10061392.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang H, Jiang B, et al. Current views on neuropeptides in atopic dermatitis. Exp Dermatol. 2021;30(11):1588–1597. doi:10.1111/exd.14382.
   PubMed Web of Science ®Google Scholar
• Mansouri Y, Guttman-Yassky E. Immune pathways in atopic dermatitis, and definition of biomarkers through broad and targeted therapeutics. J Clin Med. 2015;4(5):858–873. doi:10.3390/jcm4050858.
   PubMed Web of Science ®Google Scholar
• Tokura Y, Hayano S. Subtypes of atopic dermatitis: from phenotype to endotype. Allergol Int. 2022;71(1):14–24. doi:10.1016/j.alit.2021.07.003.
   PubMed Web of Science ®Google Scholar
• Liu L, Song G, Song Z. Intrinsic atopic dermatitis and extrinsic atopic dermatitis: similarities and differences. CCID. 2022;15:2621–2628. doi:10.2147/CCID.S391360.
   Google Scholar
• Czarnowicki T, He H, Krueger JG, et al. Atopic dermatitis endotypes and implications for targeted therapeutics. J Allergy Clin Immunol. 2019;143(1):1–11. doi:10.1016/j.jaci.2018.10.032.
   PubMed Web of Science ®Google Scholar
• Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci. 2010;58(1):1–7. doi:10.1016/j.jdermsci.2010.02.008.
   PubMed Web of Science ®Google Scholar
• Zhou B, Peng C, Li L, et al. Efficacy and safety of dupilumab in chinese patients with atopic dermatitis: a Real-World study. Front Med. 2022; 9:838030. doi:10.3389/fmed.2022.838030.
   Google Scholar
• Martel BC, Litman T, Hald A, et al. Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis. Exp Dermatol. 2016;25(6):453–459. doi:10.1111/exd.12967.
   PubMed Web of Science ®Google Scholar
• Pugliarello S, Cozzi A, Gisondi P, et al. Phenotypes of atopic dermatitis. J Dtsch Dermatol Ges. 2011;9(1):12–20. doi:10.1111/j.1610-0387.2010.07508.x.
   PubMed Web of Science ®Google Scholar
• Suárez-Fariñas M, Dhingra N, Gittler J, et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013;132(2):361–370. doi:10.1016/j.jaci.2013.04.046.
   PubMed Web of Science ®Google Scholar
• Hu Y, Liu S, Liu P, et al. Clinical relevance of eosinophils, basophils, serum total IgE level, allergen-specific IgE, and clinical features in atopic dermatitis. J Clin Lab Anal. 2020; 34:e23214.
   PubMed Web of Science ®Google Scholar
• Hon KL, Wang SS, Pong NH, et al. Circulating immunoglobulins, leucocytes and complements in childhood-onset atopic eczema. Indian J Pediatr. 2013;80(2):128–131. doi:10.1007/s12098-012-0810-0.
   PubMed Web of Science ®Google Scholar
• Kasperkiewicz M, Mook SC, Knuth-Rehr D, et al. IgE-Selective immunoadsorption for severe atopic dermatitis. Front Med. 2018;5:27. doi:10.3389/fmed.2018.00027.
   Web of Science ®Google Scholar
• Somos S, Schneider I, Farkas B. Immunoglobulins in tears and sera in patients with atopic dermatitis. Allergy Asthma Proc. 2001;22(2):81–86. doi:10.2500/108854101778250571.
   PubMed Web of Science ®Google Scholar
• Celiksoy MH, Topal E, Sancak R, et al. Relationship between hypogammaglobulinemia and severity of atopic dermatitis. Ann Allergy Asthma Immunol. 2014;113(4):467–469. doi:10.1016/j.anai.2014.06.025.
   PubMed Web of Science ®Google Scholar
• Valdés Sánchez AF, Gómez Echevarría AH, Lastra Alfonso G. Atopic dermatitis: serum immunoglobulins and T-lymphocyte subpopulations. J Investig Allergol Clin Immunol. 1991;1(2):154–158.
   PubMed Web of Science ®Google Scholar
• Braathen LR, Førre O, Natvig JB, et al. Lymphocyte subpopulations, serum immunoglobulins and complement factors in patients with atopic dermatitis. Br J Dermatol. 1978;98(5):521–528. doi:10.1111/j.1365-2133.1978.tb01937.x.
   PubMed Web of Science ®Google Scholar
• Abdullraheem YF, Alzolibani AA, Mahmoud KH, et al. Clinical study and assessment of leukocyte phagocytic function in children with atopic dermatitis in qassim region of Saudi Arabia. Int J Health Sci. 2017; 11:3–7.
   Google Scholar
• Kapp A, Wokalek H, Schöpf E. Involvement of complement in psoriasis and atopic dermatitis–measurement of C3a and C5a, C3, C4 and C1 inactivator. Arch Dermatol Res. 1985;277(5):359–361. doi:10.1007/BF00509233.
   PubMed Web of Science ®Google Scholar
• Wang H, Liu M. Complement C4, infections, and autoimmune diseases. Front Immunol. 2021;12:694928. doi:10.3389/fimmu.2021.694928.
   PubMedGoogle Scholar
• Gilliam BE, Wolff AE, Moore TL. Partial C4 deficiency in juvenile idiopathic arthritis patients. J Clin Rheumatol. 2007;13(5):256–260. doi:10.1097/RHU.0b013e318156b9e3.
   PubMed Web of Science ®Google Scholar
• Vestergaard C, Just H, Baumgartner Nielsen J, et al. Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis. Acta Derm Venereol. 2004;84(5):353–358. doi:10.1080/00015550410034444.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Akdis M. Immunological differences between intrinsic and extrinsic types of atopic dermatitis. Clin Exp Allergy. 2003;33(12):1618–1621. doi:10.1111/j.1365-2222.2003.01803.x.
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Beck LA, Blauvelt A, et al. Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS). Br J Dermatol. 2020;182(5):1120–1135. doi:10.1111/bjd.18434.
   PubMed Web of Science ®Google Scholar
• Yatagai T, Shimauchi T, Yamaguchi H, et al. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment. J Dermatol Sci. 2018;89(1):33–39. doi:10.1016/j.jdermsci.2017.10.011.
   PubMed Web of Science ®Google Scholar
• Kägi MK, Joller-Jemelka H, Wüthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology. 1992;185(2):88–92. doi:10.1159/000247419.
   PubMed Web of Science ®Google Scholar
• Ohtsuka T. Different effect of oral cyclosporine therapy and oral antihistamine therapy on serum high-sensitivity C-reactive protein level and thymus and activation-regulated chemokine level in atopic dermatitis in older children and adulthood. Int J Dermatol. 2015;54(6):648–655. doi:10.1111/ijd.12374.
   PubMed Web of Science ®Google Scholar
• Vekaria AS, Brunner PM, Aleisa AI, et al. Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity. F1000Res. 2017; 6:1712. doi:10.12688/f1000research.12422.2.
   PubMedGoogle Scholar
• Brigden ML. Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician. 1999;60(5):1443–1450.
   PubMed Web of Science ®Google Scholar
• Wüthrich B, Joller-Jemelka H, Helfenstein U, et al. Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis. Dermatologica. 1990;181(2):92–97. doi:10.1159/000247893.
   PubMedGoogle Scholar
• Kee JY, Jeon YD, Kim DS, et al. Korean red ginseng improves atopic dermatitis-like skin lesions by suppressing expression of proinflammatory cytokines and chemokines in vivo and in vitro. J Ginseng Res. 2017;41(2):134–143. doi:10.1016/j.jgr.2016.02.003.
   PubMed Web of Science ®Google Scholar